BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31483924)

  • 1. Glutathione transferase genotypes may serve as determinants of risk and prognosis in renal cell carcinoma.
    Pljesa-Ercegovac M; Savic-Radojevic A; Coric V; Radic T; Simic T
    Biofactors; 2020 Mar; 46(2):229-238. PubMed ID: 31483924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTM1 genotype is an independent prognostic factor in clear cell renal cell carcinoma.
    Coric VM; Simic TP; Pekmezovic TD; Basta-Jovanovic GM; Savic-Radojevic AR; Radojevic-Skodric SM; Matic MG; Suvakov SR; Dragicevic DP; Radic TM; Dzamic ZM; Pljesa-Ercegovac MS
    Urol Oncol; 2017 Jun; 35(6):409-417. PubMed ID: 28284893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the glutathione S-transferase genes polymorphisms in the risk and prognosis of renal cell carcinomas. Case-control and meta-analysis.
    Abid A; Ajaz S; Khan AR; Zehra F; Hasan AS; Sultan G; Mohsin R; Hashmi A; Niamatullah N; Rizvi SA; Mehdi SQ; Khaliq S
    Urol Oncol; 2016 Sep; 34(9):419.e1-419.e12. PubMed ID: 27185341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of renal carcinoma: the nutri-genetic approach].
    Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
    J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
    Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
    Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione transferase activities in renal carcinomas and adjacent normal renal tissues: factors influencing renal carcinogenesis induced by xenobiotics.
    Delbanco EH; Bolt HM; Huber WW; Beken S; Geller F; Philippou S; Brands FH; Brüning T; Thier R
    Arch Toxicol; 2001 Jan; 74(11):688-94. PubMed ID: 11218045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms.
    Karami S; Boffetta P; Rothman N; Hung RJ; Stewart T; Zaridze D; Navritalova M; Mates D; Janout V; Kollarova H; Bencko V; Szeszenia-Dabrowska N; Holcatova I; Mukeria A; Gromiec J; Chanock SJ; Brennan P; Chow WH; Moore LE
    Carcinogenesis; 2008 Aug; 29(8):1567-71. PubMed ID: 18566013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.
    Tan X; Wang Y; Han Y; Chang W; Su T; Hou J; Xu D; Yu Y; Ma W; Thompson TC; Cao G
    Br J Cancer; 2013 Dec; 109(12):3105-15. PubMed ID: 24157827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma.
    Coric VM; Simic TP; Pekmezovic TD; Basta-Jovanovic GM; Savic Radojevic AR; Radojevic-Skodric SM; Matic MG; Dragicevic DP; Radic TM; Bogdanovic LM; Dzamic ZM; Pljesa-Ercegovac MS
    PLoS One; 2016; 11(8):e0160570. PubMed ID: 27500405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
    Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between the GSTM1 null genotype and risk of renal cell carcinoma: a meta-analysis.
    Liu R; Wang XH; Liu L; Zhou Q
    Asian Pac J Cancer Prev; 2012; 13(7):3109-12. PubMed ID: 22994718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of glutathione transferase M1, T1, and P1 gene polymorphisms in the genetic susceptibility of North Indian population to renal cell carcinoma.
    Ahmad ST; Arjumand W; Seth A; Kumar Saini A; Sultana S
    DNA Cell Biol; 2012 Apr; 31(4):636-43. PubMed ID: 22054067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals.
    Buzio L; De Palma G; Mozzoni P; Tondel M; Buzio C; Franchini I; Axelson O; Mutti A
    Occup Environ Med; 2003 Oct; 60(10):789-93. PubMed ID: 14504370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.
    Qin C; Cao Q; Ju X; Wang M; Meng X; Zhu J; Yan F; Li P; Ding Q; Chen J; Gu M; Zhang W; Yin C; Zhang Z
    Ann Oncol; 2012 Apr; 23(4):981-9. PubMed ID: 21778301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development.
    Stojkovic Lalosevic ML; Coric VM; Pekmezovic TD; Simic TP; Pljesa Ercegovac MS; Pavlovic Markovic AR; Krivokapic ZV
    Pathol Oncol Res; 2019 Oct; 25(4):1579-1587. PubMed ID: 30694518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
    Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered antioxidant capacity in human renal cell carcinoma: role of glutathione associated enzymes.
    Pljesa-Ercegovac M; Mimic-Oka J; Dragicevic D; Savic-Radojevic A; Opacic M; Pljesa S; Radosavljevic R; Simic T
    Urol Oncol; 2008; 26(2):175-81. PubMed ID: 18312938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analyses of the relationship between glutathione S-transferase gene polymorphisms and renal cell carcinoma susceptibility.
    Zhong Z; Li H; Zhong H; Zhou T; Xie W; Lin Z
    BMC Med Genet; 2018 Jun; 19(1):98. PubMed ID: 29884137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.